ALS logo

ALQ - ALS Share Price

A$10.03 -0.0  -0.2%

Last Trade - 7:10am

Large Cap
Market Cap £2.69bn
Enterprise Value £3.18bn
Revenue £971.7m
Position in Universe 121st / 1902
Unlock ALQ Revenue
Relative Strength (%)
1m -3.17%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -14.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
1,422 1,239 1,262 1,447 1,665 1,832 1,763 1,937 +5.2%
-28.4 -24.8 +11.4 +21.9 +32.1 +3.5 -3.64 +21.8
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 September 2020, ALS Ltdrevenues decreased 9% to A$838.8M. Net income beforeextraordinary items decreased 20% to A$70.3M. Revenuesreflect a decrease in demand for the Company's products andservices due to unfavorable market conditions. Net incomealso reflects Amortisation on right-of-use assets increaseof 10% to A$22.7M (expense), Amortisation and depreciationincrease of 5% to A$43.7M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


ALQ Revenue Unlock ALQ Revenue

Net Income

ALQ Net Income Unlock ALQ Revenue

Normalised EPS

ALQ Normalised EPS Unlock ALQ Revenue

PE Ratio Range

ALQ PE Ratio Range Unlock ALQ Revenue

Dividend Yield Range

ALQ Dividend Yield Range Unlock ALQ Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
ALQ EPS Forecasts Unlock ALQ Revenue
Profile Summary

ALS Limited is a testing services provider. The principal activities of the Company are the provision of professional technical services in the areas of testing, measurement, inspection and monitoring; food and pharmaceutical quality assurance; mining and mineral exploration; commodity certification; equipment maintenance, and asset care operations. The Company's segments include: ALS Life Sciences, which provides testing data to assist consulting and engineering firms, industry and governments; ALS Industrial, which provides the energy, resources and infrastructure sectors with asset care and tribology testing services; Commodities, which provides assaying and metallurgical services for mining and mineral exploration companies and provides specialist services to the coal industry such as coal sampling, analysis and certification and formation evaluation services.

Last Annual March 31st, 2020
Last Interim September 30th, 2020
Incorporated December 8, 1910
Public Since July 18, 1952
No. of Shareholders: 8,862
No. of Employees: 15,638
Sector Industrials
Industry Professional & Commercial Services
Index S&P/ASX All Ordinaries , S&P/ASX 100 , S&P/ASX 200 , S&P/ASX 300 , S&P/ASX MidCap 50 , FTSE Developed Asia Pacific , FTSE Developed Asia Pacific Ex Japan ,
Exchange Australian Stock Exchange - SEATS
Shares in Issue 482,425,769
Free Float (0.0%)
Eligible for
ALQ Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for ALQ
Upcoming Events for ALQ
Wednesday 26th May, 2021
Full Year 2021 ALS Ltd Earnings Release
Wednesday 28th July, 2021
ALS Ltd Annual Shareholders Meeting
Frequently Asked Questions for ALS
What is the ALS share price?

As of 7:10am, shares in ALS are trading at A$10.03, giving the company a market capitalisation of £2.69bn. This share price information is delayed by 15 minutes.

How has the ALS share price performed this year?

Shares in ALS are currently trading at A$10.03 and the price has moved by 59.27% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the ALS price has moved by 18.43% over the past year.

What are the analyst and broker recommendations for ALS?

Of the analysts with advisory recommendations for ALS, there are there are currently 2 "buy" , 3 "hold" and 0 "sell" recommendations. The overall consensus recommendation for ALS is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will ALS next release its financial results?

ALS is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the ALS dividend yield?

The ALS dividend yield is 1.45% based on the trailing twelve month period.

Does ALS pay a dividend?

Last year, ALS paid a total dividend of 0.15, and it currently has a trailing dividend yield of 1.45%. Looking ahead, ALS has not announced an ex-dividend date yet.

When does ALS next pay dividends?

ALS has yet to annouce their ex-dividend date. The historic dividend yield on ALS shares is currently 1.45%.

How do I buy ALS shares?

To buy shares in ALS you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of ALS?

Shares in ALS are currently trading at A$10.03, giving the company a market capitalisation of £2.69bn.

Where are ALS shares listed? Where are ALS shares listed?

Here are the trading details for ALS:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: ALQ
What kind of share is ALS?

Based on an overall assessment of its quality, value and momentum, ALS is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a ALS share price forecast 2021?

Shares in ALS are currently priced at A$10.03. At that level they are trading at 5.52% discount to the analyst consensus target price of 0.00.

Analysts covering ALS currently have a consensus Earnings Per Share (EPS) forecast of 0.367 for the next financial year.

How can I tell whether the ALS share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ALS. Over the past six months, the relative strength of its shares against the market has been -8.23%. At the current price of A$10.03, shares in ALS are trading at 5.49% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the ALS PE Ratio?

The ALS PE ratio based on its reported earnings over the past 12 months is 69.58. The shares are currently trading at A$10.03.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of ALS?

ALS's management team is headed by:

Bruce McDonald - GMG
Raj Naran - CEO
Kristen Walsh - GMG
John Mulcahy - NID
Bruce Phillips - NEC
Tonianne Dwyer - NID
Michael Pearson - SEC
Tim Kilmister - GMG
Andreas Jonsson - GMG
Siddhartha Kadia - NID
Leslie Desjardins - NID
Luis Damasceno - CFO
Who are the major shareholders of ALS?

Here are the top five shareholders of ALS based on the size of their shareholding:

First Sentier Investors Investment Advisor
Percentage owned: 4.61% (22.2m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 2.45% (11.8m shares)
Impax Asset Management Ltd. Investment Advisor
Percentage owned: 2.41% (11.6m shares)
Faircase Proprietary Ltd. Corporation
Percentage owned: 1.62% (7.80m shares)
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund
Percentage owned: 1.6% (7.74m shares)
Similar to ALQ
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.